Background and Aims The prognostic ability of α-fetoprotein (AFP) for patients with
hepatocellular carcinoma (HCC) was examined by using different cutoff values. The optimal …

Abstract Background and Aim: Repeat hepatic resection for recurrent hepatocellular
carcinoma (HCC) is effective in improving long‐term outcome in selected patients. In the …

Background The role of serum alpha-fetoprotein (AFP) levels in the surveillance and
diagnosis of hepatocellular carcinoma (HCC) is controversial. The aim of this study was to …

AIM: To identify the role of alpha-fetoprotein (AFP) mRNA expression in peripheral blood
one week after surgery as a predictor for recurrence of hepatocellular carcinoma (HCC) …

Aim: The micro‐total analysis system (µTAS), a fully automated immunoassay system using
microchip capillary electrophoresis, is highly sensitive and able to quickly assay the AFP …

Background Milan criteria (MC) represent the most commonly adopted criteria for the
selection of patients with hepatocellular carcinoma (HCC) waiting for liver transplantation …

Background The postresection alpha-fetoprotein (AFP) in cirrhotic patients with
hepatocellular carcinoma (HCC) may predict overall survival (OS) and recurrence beyond …

Background Hepatocellular carcinoma (HCC) patients still have risk for very late recurrence
after curative resection. This study assesses prognostic factors in HCC patients with …

Methods From the July 2000 to July 2006, 144 patients underwent hepatic resection for HCC
at a single institution. After excluding those with ruptured HCC, combined or mixed HCC …

Background Complex hepatocellular carcinoma (HCC) prognostic biomarkers have been
reported in various studies. We aimed to establish biomarkers that could predict prognosis …